 PITTSBURGH, March 18, 2022 GLOBE NEWSWIRE -- Krystal Biotech, Inc., Krystal NASDAQ: KRYS, the leader in redosable gene therapies for rare diseases, today announced that it will present late-breaking research at the 2022 American Academy of Dermatology Annual Meeting, taking place March 25-29 in Boston, Mass. 